A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Pulmonary Arterial HypertensionPulmonary Hypertension
Interventions
DRUG

treprostinil sodium

Trial Locations (8)

44106

University Hospitals of Cleveland, Cleveland

48106

University of Michigan, Ann Arbor

60612

The Rush Heart Institute Center for Pulmonary Heart Disease, Chicago

77030

Baylor College of Medicine, Houston

84143

LDS Hospital, Salt Lake City

90033

University of Southern California, Los Angeles

90502

Harbor-UCLA Medical Center, Torrance

02114

Massachusetts General Hospital, Boston

Sponsors
All Listed Sponsors
lead

United Therapeutics

INDUSTRY